Cite

HARVARD Citation

    Bogen, D. et al. (n.d.). The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma. International journal of cancer. 139 (1), pp. 153-163. [Online]. 
  
Back to record